The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

• Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
• New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
• Consensus recommendations for the preferred and alternative treatments for common disorders
• Our signature tables that make comparing drugs quick and easy
• Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
• Objective drug information–free of advertising and commercial influence